Onconetix Inc (ONCE) Stock Price, Quote, News and Overview
NASDAQ:ONCE - Nasdaq - - Currency: USD
ONCE Quote, Performance and Key Statistics
113.57
+2.82 (+2.55%)
The current stock price of ONCE is 113.57 USD. In the past month the price increased by 2.49%. In the past year, price increased by 206.86%.
About ONCE
Company Profile
Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.
Company Info
Onconetix Inc
3737 MARKET STREET SUITE 1300
PHILADELPHIA PA 19104
CEO: Jeffrey D. Marrazzo
Phone: 888-772-7560
Onconetix Inc / ONCE FAQ
What is the stock price of Onconetix Inc today?
The current stock price of ONCE is 113.57 USD. The price increased by 2.55% in the last trading session.
What is the ticker symbol for Onconetix Inc stock?
The exchange symbol of Onconetix Inc is ONCE and it is listed on the Nasdaq exchange.
On which exchange is ONCE stock listed?
ONCE stock is listed on the Nasdaq exchange.
What is Onconetix Inc worth?
Onconetix Inc (ONCE) has a market capitalization of 4.38B USD. This makes ONCE a Mid Cap stock.
What are the support and resistance levels for Onconetix Inc (ONCE) stock?
Onconetix Inc (ONCE) has a support level at 112.09 and a resistance level at 113.88. Check the full technical report for a detailed analysis of ONCE support and resistance levels.
Should I buy Onconetix Inc (ONCE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ONCE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ONCE, evaluating the profitability, health, valuation and growth aspects
- Onconetix Inc (ONCE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Onconetix Inc (ONCE) Sales and EPS estimates to see what analysts future expectations are.
- Onconetix Inc (ONCE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Onconetix Inc (ONCE) Insider and Institutional Ownership to learn about the owners and their transactions.
- Onconetix Inc (ONCE) Stock Chart to make your own analysis
- Onconetix Inc (ONCE) Latest news and press-releases to stay up to date.
Does Onconetix Inc (ONCE) stock pay dividends?
ONCE does not pay a dividend.
What is the Price/Earnings (PE) ratio of Onconetix Inc (ONCE)?
Onconetix Inc (ONCE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.56).
ONCE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ONCE. When comparing the yearly performance of all stocks, ONCE is one of the better performing stocks in the market, outperforming 98.44% of all stocks.
ONCE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ONCE. The financial health of ONCE is average, but there are quite some concerns on its profitability.
ONCE Financial Highlights
Over the last trailing twelve months ONCE reported a non-GAAP Earnings per Share(EPS) of -6.56. The EPS decreased by -202.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -358.41% | ||
| ROA | -35.6% | ||
| ROE | N/A | ||
| Debt/Equity | 0.35 |
ONCE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to ONCE. The Buy consensus is the average rating of analysts ratings from 9 analysts.